The role of Cdk5 in retinoic acid-induced apoptosis of cervical cancer cell line

Chinese Journal of Physiology

Volumn 52, Issue 1, 2009, Pages 23-30

  Kuo, Hung Shou ^a   Hsu, Fu Ning ^a   Chiang, Ming Ching ^a   You, Shuen Chi ^a   Chen, Mei Chih ^c   Lo, Ming Jae ^b   Lin, Ho ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL TAICHUNG UNIVERSITY OF EDUCATION   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cdk5; HeLa cells; p35; Retinoic acid

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE 5; LIPOCORTIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P35; RETINOIC ACID; ROSCOVITINE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; PROTEIN FUNCTION; STAINING; UTERINE CERVIX CANCER;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL CYCLE PROTEINS; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE 5; FEMALE; G1 PHASE; GROWTH INHIBITORS; HELA CELLS; HUMANS; PURINES; RNA, SMALL INTERFERING; TRETINOIN; UTERINE CERVICAL NEOPLASMS;

EID: 70349554363     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2009.AMG067     Document Type: Article

References (26)

1. Ahuja, H.S., Szanto, A., Nagy, L. and Davies, P.J. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death. J. Biol. Regul. Homeost. Agents 17: 29-45, 2003.
2. Alvarez, A., Munoz, J.P. and Maccioni, R.B. A Cdk5-p35 stable complex is involved in the β-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp. Cell Res. 264: 266-274, 2001.
3. 2+ entry after retinoic acid-induced differentiation of neuroblastoma cells. Biochem. J. 388: 941-948, 2005.
4. Chergui, K., Svenningsson, P. and Greengard, P. Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl. Acad. Sci. U.S.A. 101: 2191-2196, 2004.
5. Chomienne, C., Fenaux, P. and Degos, L. Retinoid differentiation therapy in promyelocytic leukemia. FASEB J. 10: 1025-1030, 1996.
6. Geisen, C., Denk, C., Kupper, J.H. and Schwarz, E. Growth inhibition of cervical cancer cells by the human retinoic acid receptor β gene. Int. J. Cancer 85: 289-295, 2000.
7. Hong, W.K., Lippman, S.M., Itri, L.M., Karp, D.D., Lee, J.S., Byers, R.M., Schantz, S.P., Kramer, A.M., Lotan, R., Peters, L.J., Dimery, I.W., Brown, B.W. and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 323: 795-801, 1990.
8. Hsu, S.L., Chen, M.C., Chou, Y.H., Hwang, G.Y. and Yin, S.C. Induction of p21(CIP1/Waf1) and activation of p34 (cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells. Exp. Cell Res. 248: 87-96, 1999.
9. Kerokoski, P., Suuronen, T., Salminen, A., Soininen, H. and Pirttila, T. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis. Biochem. Biophys. Res. Commun. 280: 998-1002, 2001.
10. Kraemer, K.H., DiGiovanna, J.J., Moshell, A.N., Tarone, R. E. and Peck, G. L. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N. Engl. J. Med. 318: 1633-1637, 1988.
11. Kwon, Y.T., Gupta, A., Zhou, Y., Nikolic, M. and Tsai, L.H. Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr. Biol. 10: 363-372, 2000.
12. Lee, S.Y., Wenk, M.R., Kim, Y., Nairn, A.C. and De Camilli, P. Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc. Natl. Acad. Sci. U.S.A. 101: 546-551, 2004.
13. Lew, J., Beaudette, K., Litwin, C.M. and Wang, J.H. Purification and characterization of a novel proline-directed protein kinase from bovine brain. J. Biol. Chem. 267: 13383-13390, 1992.
14. Lin, H., Chen, M.C., Chiu, C.Y., Song, Y.M. and Lin, S.Y. Cdk5 regulates STAT3 activation and cell proliferation in medullary thyroid carcinoma cells. J. Biol. Chem. 282: 2776-2784, 2007.
15. Lin, H., Juang, J.L. and Wang, P.S. Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. J. Biol. Chem. 279: 29302-29307, 2004.
16. Lin, H., Lin, T.Y. and Juang, J.L. Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration. Cell. Death Differ. 14: 607-615, 2007.
17. Lotan, R. Retinoids and apoptosis: implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87: 1655-1657, 1995.
18. Mark, M., Ghyselinck, N.B. and Chambon, P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu. Rev. Pharmacol. Toxicol. 46: 451-480, 2006.
19. McCaffery, P., Zhang, J. and Crandall, J.E. Retinoic acid signaling and function in the adult hippocampus. J. Neurobiol. 66: 780-791, 2006.
20. Neystat, M., Rzhetskaya, M., Oo, T.F., Kholodilov, N., Yarygina, O., Wilson, A., El-Khodor, B.F. and Burke, R.E. Expression of cyclin-dependent kinase 5 and its activator p35 in models of induced apoptotic death in neurons of the substantia nigra in vivo. J. Neurochem. 77: 1611-1625, 2001.
21. Nikolic, M., Dudek, H., Kwon, Y.T., Ramos, Y.F. and Tsai, L.H. The cdk5/ p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10: 816-825, 1996.
22. Paglini, G., Pigino, G., Kunda, P., Morfini, G., Maccioni, R., Quiroga, S., Ferreira, A. and Caceres, A. Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J. Neurosci. 18: 9858-9869, 1998.
23. Piacentini, M., Annicchiarico-Petruzzelli, M., Oliverio, S., Piredda, L., Biedler, J.L. and Melino, E. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer 52: 271-278, 1992.
24. Smith, M.A., Parkinson, D.R., Cheson, B.D. and Friedman, M.A. Retinoids in cancer therapy. J. Clin. Oncol. 10: 839-864, 1992.
25. Um, S.J., Kim, E.J., Hwang, E.S., Kim, S.J., Namkoong, S.E. and Park, J.S. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: cooperative growth suppression of IRF-1 and p53. Int. J. Cancer 85: 416-423, 2000.
26. Zhang, J., Krishnamurthy, P.K. and Johnson, G.V. Cdk5 phosphorylates p53 and regulates its activity. J. Neurochem. 81: 307-313, 2002.